FDA Approvals for Liver and Stomach Cancer Extend the Reach of Immunotherapy

Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics known as checkpoint inhibitors are a treatment option when it expanded the approved uses of nivolumab (Opdivo) and pembrolizumab (Keytruda) to include certain patients with liver cancer and stomach cancer, respectively.

Read More

Turning a Diagnosis into a Dream for a Cure

After being diagnosed with stage 4 stomach cancer, Debbie Zelman, Esq., started Debbie’s Dream Foundation: Curing Stomach Cancer (DDF) to fund critical biomedical research focused on the disease. In 2014, DDF became a valued partner of the AACR, supporting the very first Debbie’s Dream Foundation-AACR Gastric Cancer Research Fellowship.

Read More